OBERWEIS ASSET MANAGEMENT INC/ - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 123 filers reported holding ANI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,915,980
-69.4%
33,000
-79.1%
0.20%
-88.8%
Q3 2015$6,252,000
-30.4%
158,235
+9.3%
1.82%
-23.3%
Q2 2015$8,984,000
+98.0%
144,785
+99.6%
2.38%
+86.6%
Q1 2015$4,537,000
+379.1%
72,535
+331.8%
1.27%
+350.2%
Q4 2014$947,00016,8000.28%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders